Alternative Conversion Methods for Transition Probabilities in State-Transition Models: Validity and Impact on Comparative Effectiveness and Cost-Effectiveness

Abstract

Background. In state-transition models (STMs), decision problems are conceptualized using health states and transitions among those health states after predefined time cycles. The naive, commonly applied method (C) for cycle length conversion transforms all transition probabilities separately. In STMs with more than 2 health states, this method is not accurate. Therefore, we aim to describe and compare the performance of method C with that of alternative matrix transformation methods. Design. We compare 2 alternative matrix transformation methods (Eigenvalue method [E], Schure-Padé method [SP]) to method C applied in an STM of 3 different treatment strategies for women with breast cancer. We convert the given annual transition matrix into a monthly-cycle matrix and evaluate induced transformation errors for the transition matrices and the long-term outcomes: life years, quality-adjusted life-years, costs and incremental cost-effectiveness ratios, and the performance related to the decisions. In addition, we applied these transformation methods to randomly generated annual transition matrices with 4, 7, 10, and 20 health states. Results. In theory, there is no generally applicable correct transformation method. Based on our simulations, SP resulted in the smallest transformation-induced discrepancies for generated annual transition matrices for 2 treatment strategies. E showed slightly smaller discrepancies than SP in the strategy, where one of the direct transitions between health states was excluded. For long-term outcomes, the largest discrepancy occurred for estimated costs applying method C. For higher dimensional models, E performs best. Conclusions. In our modeling examples, matrix transformations (E, SP) perform better than transforming all transition probabilities separately (C). Transition probabilities based on alternative conversion methods should therefore be applied in sensitivity analyses.

Keywords

conversion transition probability cost-effectiveness analysis markov model markov transition matrix state-transition model

Get full access to this article

View all access options for this article.

References

Siebert

Alagoz

Bayoumi

, et al. State-transition modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force 3. Med Decis Making. 2012;32:690–700.

Siebert

Alagoz

Bayoumi

, et al. State-transition modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force 3. Value Health. 2012;15:812–20.

Siebert

When should decision-analytic modeling be used in the economic evaluation of health care?

Eur J Health Econ. 2003;4(3):143–50.

Sonnenberg

Beck

JR.

Markov models in medical decision making: a practical guide. Med Decis Making. 1993;13(4):322–38.

Beck

Pauker

SG.

The Markov process in medical prognosis. Med Decis Making. 1983;3:419–58.

Hunink

MGM

Glasziou

Siegel

, et al. Decision Making in Health and Medicine: Integrating Evidence and Values. Cambridge, UK: Cambridge University Press; 2001.

Briggs

Claxton

Sculpher

Decision Modelling for Health Economic Evaluation. Oxford, UK: Oxford University Press; 2006.

Chhatwal

Jayasuriya

Elbasha

EH.

Changing cycle lengths in state-transition models: challenges and solutions. Med Decis Making. 2016;36(8):952–64.

Welton

Ades

AE.

Estimation of Markov chain transition probabilities and rates from fully and partially observed data: uncertainty propagation, evidence synthesis, and model calibration. Med Decis Making. 2005;25(6):633–45.

10.

Jones

Epstein

García-Mochón

A procedure for deriving formulas to convert transition rates to probabilities for multistate Markov models. Med Decis Making. 2017;37(7):779–89.

11.

Lando

Skodeberg

TM.

Analyzing rating transitions and rating drift with continuous observations. J Banking Finance. 2002;26(2–3):423–44.

12.

Arvantis

Gregory

Laurent

J-P.

Building models for credit spreads. J Derivatives. 1999;6(3):27–43.

13.

Jarrow

Lando

Turnbull

SM.

A Markov model for the term structure of credit risk spreads. Rev Financial Stud. 1997;10:481–523.

14.

Israel

Rosenthal

Wei

JZ.

Finding generators for Markov chains via empirical transition matrices, with applications to credit ratings. Math Finance. 2001;11(2):245–65.

15.

Singer

Spilerman

The representation of social processes by Markov models. Am J Sociol. 1976;82(1):1–54.

16.

Kuntz

Weinstein

MC.

Modeling in economic evaluations. In: Drummond

McGuire

, eds. Economic Evaluation in Health Care: Merging Theory with Practice. New York: Oxford University Press; 2001.

17.

Lin

Roots of Stochastic Matrices and Fractional Matrix Powers. 2011. Available from: https://www.escholar.manchester.ac.uk/api/datastream?publicationPid=uk-ac-man-scw:106850&datastreamId=FULL-TEXT.PDF

18.

Charitos

de Waal

van der Gaag

LC.

Computing short-interval transition matrices of a discrete-time Markov chain from partially observed data. Stat Med. 2008;27(6):905–21.

19.

Horn

Johnson

CR.

Matrix Analysis. Cambridge, UK: Cambridge University Press; 2012.

20.

Kingman

JFC

. The imbedding problem for finite Markov chains. Z Wahrsch. 1962;1:14–24.

21.

Goulet

Dutang

Maechler

, et al. Package expm. 2015. Available from: https://cran.r-project.org/web/packages/expm/expm.pdf

22.

Higham

Lin

A Schur-Padé Algorith for Fractional Powers of a Matrix. SIAM J Matrix Anal Appl. 2011;32(3):1056–78.

23.

Jones

MT.

24.

Craig

Sendi

PP.

Estimation of the transition matrix of a discrete-time Markov chain. Health Econ. 2002;11(1):33–42.

25.

McLachlan

Krishnan

The EM Algorithm and Extensions. 2nd ed. New York: John Wiley; 2000.

26.

Borg

Persson

Jess

, et al. A maximum likelihood estimator of a Markov model for disease activity in Crohn’s disease and ulcerative colitis for annually aggregated partial observations. Med Decis Making. 2010;30(1):132–42.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.28 MB